ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP)

45.49
0.12
(0.26%)
Closed October 07 4:00PM
45.49
0.00
( 0.00% )
Pre Market: 7:34AM

CRISPR Therapeutics AG Financial Summary

The current CRSP market cap is 3.87B. The company's latest EPS is USD -1.8036 and P/E is -25.22.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 70M0201.21M504k517k
Operating Income -76.82M-111.74M89.58M-115.87M-125.12M
Net Income -77.74M-112.15M89.35M-116.59M-126.41M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 289.59M719k914.96M1.2M371.21M
Operating Income 67.31M-348.06M379.53M-650.5M-150.72M
Net Income 66.86M-348.87M377.66M-650.18M-153.61M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 2.2B2.09B2.23B2.44B2.34B
Total Liabilities 380.99M359.04M346.77M355.08M358.9M
Total Equity 1.82B1.73B1.88B2.08B1.98B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.07B1.83B2.75B2.24B2.23B
Total Liabilities 127.33M163.73M352.42M367.58M346.77M
Total Equity 939.43M1.66B2.4B1.88B1.88B
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -124.45M-164.3M-260.38M109.75M14.17M
Investing 334.75M456.1M374.65M-97.8M-224.71M
Financing 22.17M23.73M62.66M305.93M305.47M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 56.68M-238.37M538.97M-495.74M-260.38M
Investing 1.33M-541.17M-1.04B-258.66M374.65M
Financing 430.98M1.02B250.95M38.59M62.66M
Market Cap 3.87B
Price to Earnings Ratio -25.22
Price to Sales Ratio 10.44
Price to Cash Ratio 9.95
Price to Book Ratio 2.06
Dividend Yield -

Share Statistics

Shares Outstanding 85.17M
Average Volume (1 week) 1.03M
Average Volume (1 Month) 1.06M
52 Week Change 7.21%
52 Week High 91.10
52 Week Low 37.55
Spread (Intraday) 0.53 (1.15%)

Company Info

Company Name CRISPR Therapeutics AG
Address baarerstrasse 14
zug 6300
Website https://www.crisprtx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock